Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole- — Jan Balzarini (1993) | RDL Network
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-
Rosa Álvarez, Sonsoles Velázquez, Ana San‐Félix, Stefano Aquaro, De Clercq Erik, Carlo Federico Perno, Anna Karlsson, Jan Balzarini, Marı́a-José Camarasa
Sonia de Castro, Esther Lobatón, María‐Jesús Pérez‐Pérez, Ana San‐Félix, Alessandra Cordeiro, Graciela Andreï, Robert Snoeck, De Clercq Erik, Jan Balzarini, Marı́a-José Camarasa, Sonsoles Velázquez
Discussion(0)
No comments yet. Be the first to comment.